Mayo Clinic and Microsoft both announced this week that Mayo will be among the health systems to first deploy Microsoft 365 Copilot, a generative AI platform.WHY IT MATTERSThe Rochester, Minnesota-based will be an early…
Continue Reading
Dr. Richard Tytus of Hamilton, Ontario, is a medical professional with extensive experience in delivering and promoting virtual healthcare. He has been providing telemedicine long before the COVID-19 pandemic. He is a clinic owner…
Continue Reading
Fundraise Supports Market Expansion with Summus Emerging as the Premier Clinical Platform to Share and Access High-Quality Specialty Expertise Across the Continuum of Care — Serving Employers, Payers, Health Systems, and Physician Groups
Summus, the…
Cheshire and Merseyside Integrated Care System (ICS) has signed a new agreement with tech provider C2-Ai, to expand its waiting list initiative across all of its nine acute trusts in the region.The AI-backed decision…
Continue Reading
Pharmacogenomics has the potential to save money for the health service and contribute to advances in personalised medicine, speakers told a panel at this week’s HETT conference in London, but stakeholders will need to…
Continue Reading
ADHA appoints new board chairThe Australian Digital Health Agency has assigned Lyn McGrath to their board’s chair.
McGrath has been a non-executive member of the ADHA Board for over seven years. She has also served…
Philippine state insurer temporarily shuts ransomware-hit IT systemThe Philippine Health Insurance Corporation has recently reported a cyberattack on its IT system.
A news report noted that the attack, which was carried out on the morning…
The NHS is poised to ask members of the public to help shape how the health service uses their health data in an effort to improve patient care.From the new year and until March…
Continue Reading
Top News
Patient engagement software vendor Tendo will acquire healthcare marketplace operator MDsave for $150 million.
Reader Comments
From Squeamish: “Re: Adventist Health. Heard from someone at the corporate office that they will replace Cerner with…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
